News|Articles|April 20, 2026

Early intervention during subacute phase may help prevent chronic low back pain

Listen
0:00 / 0:00

Key Takeaways

  • Longitudinal evidence links higher baseline pain intensity and early disability with markedly increased odds of poor recovery and chronic symptoms beyond 12 weeks.
  • Radiating pain is repeatedly associated with worse trajectories, indicating a clinically accessible marker for intensified monitoring during the subacute phase.
SHOW MORE

Chronic low back pain develops from a mix of clinical, psychological, biological and social factors and highlights the subacute phase as a key period for early coordinated care, according to findings from a recent study.

The shift from acute to chronic low back pain is driven by a mix of clinical, psychological, inflammatory and social factors, with the subacute phase offering a key window for early, coordinated care to help prevent long-term pain, according to a study published in March 2026 in the European Journal of Medicine.

Low back pain, especially non-specific low back pain, is one of the leading causes of disability worldwide and remains difficult to treat because it often has no clear structural cause, according to the study. While many cases improve on their own, a significant share of patients go on to develop long-lasting symptoms that can disrupt daily life, work and overall health.

Researchers of the study who hail from institutions across Germany, Italy and India noted this progression is not driven by a single issue but by a mix of physical symptoms, psychological responses, and social conditions that can shape how patients recover. Factors such as high pain levels, early loss of function, fear of movement and limited access to care can all play a role. The subacute phase, which occurs weeks after the initial injury, is now seen as a key period when these risks begin to take hold and when early, targeted care may help prevent chronic pain.

Researchers led by orthopedic and trauma surgeon Filippo Migliorini, M.D., Ph.D., MBA, MSc, examined non-specific low back pain because many patients continue to develop long-term symptoms despite early treatment, creating a major burden on patients and health systems. To better understand why this happens, the team conducted a narrative review that brought together findings from prior clinical and experimental studies on patients with low back pain.

They analyzed evidence across several domains, including clinical presentation such as pain intensity and disability; psychological factors such as fear-avoidance and catastrophizing; biological markers such as inflammatory cytokines and social influences including work strain and access to care. The researchers also reviewed biomechanical data on movement patterns, muscle activation and proprioception to see how early physical changes may contribute to chronic pain.

By integrating these different streams of evidence, the team aimed to identify shared risk factors and interactions that help explain how pain persists and to highlight the subacute phase as a key period for targeted intervention.

Results revealed that a substantial share of patients with acute low back pain don’t fully recover, with prior research cited in the review estimating that about 20% to 30% of patients progress to chronic symptoms lasting longer than 12 weeks. Patients at highest risk often report greater pain intensity at baseline along with early disability, both of which have been linked in longitudinal studies to significantly higher odds of poor recovery.

The review also points to radiating pain as a key clinical marker tied to worse outcomes. Additionally, psychosocial factors play a measurable role, with studies showing that fear-avoidance beliefs and catastrophizing are associated with increased disability scores and slower return to normal activity, particularly when these factors emerge within the four-to-12-week subacute window.

Socioeconomic pressures such as physically demanding jobs and involvement in compensation claims have also been associated with longer pain duration and higher reported disability rates. On the biological side, patients with poorer recovery trajectories tend to show elevated levels of proinflammatory cytokines such as TNF alpha and IL-6 along with reduced anti-inflammatory markers like IL-10, suggesting an imbalance in immune response even at earlier stages.

Biomechanical findings add another layer, with research noting reduced lumbar range of motion delayed activation of stabilizing muscles such as the multifidus and decreased movement variability during routine tasks.

Based on the overall methods and findings, the review’s strengths include its wide look at clinical, psychological, biological and social factors and its clear focus on the subacute phase as an important window for early treatment. It also brings attention to areas such as inflammation and movement changes that are typically missed in everyday care.

However, the authors noted key limitations, including that many studies are cross-sectional or use existing data, which makes it harder to prove cause and effect. They also point out that many studies look at factors separately instead of how they work together. In addition, current prediction tools are still limited in accuracy and real-world use.

The authors suggest future research should use long-term studies and build more complete models that combine physical, mental and social data to better guide early and targeted care.


Latest CME